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Conventional studies of cell cycle often
rely on the quantification of cellular DNA con-
tent, metabolic labeling of newly synthetized
DNA to mark S phase cells, and the detection
of cell cycle markers of various nature. How-
ever, these are all approaches that do not
allow live monitoring of cell cycle progression.
This limitation was recently overcome by the
development of fluorescent reporter genes
which allow the visual discrimination of spe-
cific cell cycle phases.1
Prominent among such reporter systems is
the Fucci (Fluorescence Ubiquitination-based
Cell Cycle Indicator), which relies on the
expression of 2 fusion proteins: mAG-hGem(1/
110) (a portion of Geminin fused to a fluores-
cent protein in the green spectrum), and
mKO2-hCdt1(30/120) (a portion of Cdt1 fused
to a fluorescent protein in the orange/red
spectrum). The stability of the resulting fluo-
rescent proteins is regulated by different ubiq-
uitination signals that are recognized by E3
ubiquitin-ligases APC and SCF, which are
active respectively in late M/G1 and in S/G2.
Therefore, these reporters mark cells in early
G1 (non fluorescent), late G1 (red), G1/S (yel-
low) and S/G2/M phase (green).2
The Fucci system or its more recent version
Fucci2 (in which mAG and mKO2 are respec-
tively replaced with mCherry and mVenus3)
have been successfully used to monitor cell
cycle progression in a variety of cell lines.2,4,5
However, the use of Fucci in vivo, especially in
mice, has been limited by the lack of condi-
tional transgene expression, varying (and
sometimes very low) expression of the fusion
proteins in different tissues, and potential tox-
icity due to non-physiological level of
overexpression.2,6
In issue 13(17) of Cell Cycle, Richard Mort
and colleagues report the generation of a
novel mouse reporter named Fucci2a, which
aims to address the limitations of previous
Fucci mice.7 Indeed, the Fucci2a mouse allows
Cre-lox mediated conditional expression of a
bicistronic transgene targeted to the Rosa26
locus in which the Fucci2 genes are joined by
a T2A sequence and driven by the strong and
ubiquitous CAG promoter (Fig. 1). This strat-
egy results in a tissue (and potentially time)
specific high and homogeneous expression of
the Fucci2 reporters in virtually all cell types,
while simplifying the maintenance of the
mouse line. As proof of principles, the authors
show that the Fucci2a mouse can be used to
investigate the cell cycle dynamics in the
developing lung and kidney. Moreover, they
demonstrate the efficacy of the Fucci2a
reporter system by monitoring cell cycle in
3T3 cells, mouse embryonic stem cells, and
migratory neural crest-derived cells.
Figure 1. Fucci2a mouse and its potential applications. The intercross of the Fucci2a mouse (top
allele) with a line expressing the CRE recombinase under a tissue specific promoter (bottom allele)
results in CRE-loxP-mediated removal of the Neo-pA cassette and activates the expression of the
Fucci2a transgene. This allows to fluorescently mark specific cells according to their cell cycle phase.
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The improvements brought by the Fucci2a
reporter system are remarkable and could
results in a diversity of applications impossible
so far. To name but some of the most intrigu-
ing, the Fucci2a mouse could be used to iden-
tify and isolate small subset of proliferating
cells in adult organs where the presence of
stem cells is still debatable. Similarly, the
Fucci2a also offers the potential to investigate
the cell cycle dynamics of stem cells and dif-
ferentiating progenitors both during embry-
onic development, organ homeostasis and in
tissue repair after injury or infections. More-
over, the Fucci2a mouse could be crossed
with genetic models for developmental
defects or adult diseases (including cancer),
hence allowing one to both investigate the
cell cycle dependent mechanisms involved in
a diversity of disorders, and screen for poten-
tial novel drugs modulating cell proliferation.
Of note, it is important to underline that
the Fucci2a system does not solve the limita-
tions intrinsic to the nature of the Fucci fusion
proteins. Indeed, overexpression of hGem(1/
110) and/or mCheery-hCdt1 (30/120) fusion
proteins may be toxic in some tissues. Further-
more, this system does no allow one to dis-
criminate between cells in G1 and G0 (both
are labeled red) or cells in S, G2 and M phase
(are all labeled green), or to visualize cells in
early G1 due to their lack of fluorescence.
However, the further development of new
cell-cycle reporters in the near future will likely
compensate for these drawbacks and the
approach shown in the present paper high-
lights a way forward to use these
developments to unlock even more of the
potential of the Fucci system.
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